Oncology Medical News about anthocyanins

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs
Cancer Chemotherapy and Pharmacology, 03/27/09

Thomasset S et al. - The pharmaceutical issues are very important determinants of the suitability of these flavonoids for potential development as cancer chemopreventive drugs, and they have hitherto not received adequate attention. In the light of their robust cancer chemopreventive efficacy in experimental models and their superior stability as compared to that of the aglycons, the anthocyanins seem much more suitable for further drug development than their anthocyanidin counterparts.

<< Previous
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for...

Next >>
Thymidylate synthetase allelic imbalance in clear cell renal...

Anti-Invasive Activity of Anthocyanins Isolated from Vitis coignetiae in Human Hepatocarcinoma Cells
Journal of Medicinal Food, 10/27/09 Relevance Score: 83%

Cardiovascular Disease Risk Biomarkers and Liver and Kidney Function Are Not Altered in Postmenopausal Women after Ingesting an Elderberry Extract Rich in Anthocyanins for 12 Weeks
The Journal of Nutrition, 10/02/09 Relevance Score: 80%